$RLX

RLX Technology Inc. (RLX): Financial results for Q2 2026

RLX Technology Inc. (RLX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 RLX Technology Announces Unaudited Second Quarter 2026 Financial Results SHENZHEN, August 14, 2026 /PRNEWSWIRE/ - RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced its unaudited financial re

Original reporting
Published Aug 14, 2026, 10:56 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 6:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RLX
Bullish
high confidence
Mentioned
$RLX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$RLXBullishMed
01

Why it matters

The earnings release provides fresh quantitative data on growth and profitability, offering traders a basis for short‑term positioning.

02

Market read

First‑hand earnings data for a mid‑cap growth company; potential catalyst for price movement.

03

What to watch

Cash balance decline and modest operating cash burn suggest capital efficiency needs monitoring.

Relevance 7/10Novelty 7/10Timing: after‑hours release on Aug 14

Background

RLX Technology is a NYSE‑listed e‑vapor company expanding into smoke‑free oral nicotine products.

Company-level read

Ticker impact

$RLXBullishHigh confidence
Context

RLX Technology reported Q2 2026 results with 14.8% revenue growth, gross margin up to 35.4% and a 28.8% rise in non‑GAAP operating income.

Expected impact

Modest upside as investors price higher margins and growth outlook.

Evidence & confidence

The combination of double‑digit revenue growth, margin expansion and strategic acquisition provides a clear catalyst for a short‑term price rally.

Market effects

Strengthens the e‑vapor and broader smoke‑free product sector, highlighting demand for premium distribution networks.

European market sees potential upside from the new 51% stake in a major distributor.

Adds to the narrative of growth in alternative nicotine products worldwide.

Counterpoint

Margin gains may be temporary if input costs rise; acquisition integration risk could pressure near‑term earnings.

Key entities

  • RLX Technology Inc.

    Subject of the earnings release.

  • Western European distributor (51% stake)

    Acquired asset expanding RLX's European footprint.

Related articles

$RLXMed

RLX Technology (RLX) Bets Big On Europe And Nicotine Pouches

RLX Technology (RLX) reported Q2 2026 revenue of RMB1.01B (+14.8% YoY), with international sales at 70% of revenue. Gross margin expanded to 35.4% due to supply chain and product mix improvements. The company acquired a 51% stake in a European distributor, aiming to build direct retail relationships. However, China revenue is expected to be flat for the year due to regulatory tightening. RLX is also investing in nicotine pouches and has RMB13.9B in capital resources.

$RLXMedAI 8/10

RLX Technology (RLX) Q2 2026 Earnings Call Transcript

RLX Technology reported Q2 2026 net revenue of RMB 1,010.5 million, up 14.8% YoY, driven by international expansion and a 2025 acquisition. Gross margin expanded to 35.4% from 27.5% YoY. International sales contributed 70% of revenue. Non-GAAP income from operations rose 28.8% YoY to RMB 149.6 million. GAAP net income increased 1.6% YoY to RMB 222.0 million. Management highlighted growth in oral nicotine pouches and a 51% investment in a European distributor.

$RLXMedAI 8/10

Robust Earnings and International Expansion Assert RLX Technology Inc. (RLX) as a Top Sin Stock to Buy

RLX Technology (NYSE:RLX) reported first-quarter results on May 20 that beat expectations, driven by international expansion. Net revenues rose 96.2% to $229.9 million and gross margin improved to 31.8% from 28.6%. Adjusted net income increased 41.4% to $51.8 million, with adjusted EPS of $0.038. International operations were 72.3% of revenue, led by Europe and Asia.

$ARAYMed

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter

Accuray (ARAY) reported a 21% revenue decline to $100.9M in Q4 2026, with China's market contributing to a 42% drop in product revenue. The company secured $60M in financing from TCW Asset Management, improving its balance sheet. Service revenue grew 6%, and cost savings exceeded targets. However, Accuray did not provide 2027 guidance due to trade policy uncertainties.

$BILLMedAI 8/10

Bill Holdings (BILL) Leans On AI To Power Its Next Chapter

Bill Holdings (BILL) reported Q4 revenue of $400.5M, up 16% YoY, with non-GAAP operating margin expanding 860 bps to 23%. AI adoption drove growth, with 175,000 businesses using AI agents. Non-GAAP net income rose 53% YoY to $94M. Management expects GAAP net profit above $125M in fiscal 2027. Growth slowed due to restructuring, with net-new customers at 1,800. Fiscal 2027 revenue growth guided to 11-14%, down from 16%.